Fludara - 50mg

Category: Cytostatic
Manufacturer: Sanofi Aventis
Composed of: Fludarabine Phosphate, Atenolol
Used for: Blood cancer,

Product Information

This medicine is used in the treatment of B-cell chronic lymphocytic leukaemia (cancer) after initial treatment with an alkylating agent has failed.

Patients using this medicine may at times experience CNS and pulmonary toxicity, and myelosuppression. If you experience any of these symptoms for a long period of time, consult your doctor immediately.

This medicine should not be used in patiens with severe hepatic (liver) dysfunction, and acute Injectionectionections.

Please consult your doctor before taking this medicine if you have any of these conditions; Hepatic or renal impairment (liver or kidney disorder) or any of the following stomach disorders like inflammatory bowel disorders, chronic ulcerations, intestinal obstructions, or chronic digestive or absorption problems.

Reviews & Comments

Disclaimer: All material on this website is provided for your information only and may not be construed as medical advice or instruction. No action or inaction should be taken based solely on the contents of this information; instead, readers should consult appropriate health professionals on any matter relating to their health and well-being. The data information and opinions expressed here are believed to be accurate, which is gathered from different sources but might have some errors. Hamariweb.com is not responsible for errors or omissions. Doctors and Hospital officials are not necessarily required to respond or go through this page.